602 related articles for article (PubMed ID: 33346525)
1. Metformin as Adjunctive Therapy for Pediatric Patients With Hidradenitis Suppurativa.
Moussa C; Wadowski L; Price H; Mirea L; O'Haver J
J Drugs Dermatol; 2020 Dec; 19(12):1231-1234. PubMed ID: 33346525
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of medical treatments for pediatric hidradenitis suppurativa: A systematic review.
Masson R; Ma E; Parvathala N; Shih T; Atluri S; Hogeling M; Hughes M; Sayed CJ; Shi VY; Hsiao JL
Pediatr Dermatol; 2023; 40(5):775-788. PubMed ID: 37525978
[TBL] [Abstract][Full Text] [Related]
3. Hormonal Treatments in Hidradenitis Suppurativa: A Systematic Review.
Masson R; Shih T; Jeong C; Shi VY; Hsiao JL
J Drugs Dermatol; 2023 Aug; 22(8):785-794. PubMed ID: 37556513
[TBL] [Abstract][Full Text] [Related]
4. Metformin use in hidradenitis suppurativa.
Jennings L; Hambly R; Hughes R; Moriarty B; Kirby B
J Dermatolog Treat; 2020 May; 31(3):261-263. PubMed ID: 30893570
[No Abstract] [Full Text] [Related]
5. Update on Hormonal Therapy in Hidradenitis Suppurativa.
Karagaiah P; Daveluy S; Ortega-Loayza A; Gulliver W; Szepietowski J; Grabbe S; Goldust M
J Drugs Dermatol; 2023 Apr; 22(4):369-374. PubMed ID: 37026880
[TBL] [Abstract][Full Text] [Related]
6. Evidence-based approach to the treatment of hidradenitis suppurativa/acne inversa, based on the European guidelines for hidradenitis suppurativa.
Gulliver W; Zouboulis CC; Prens E; Jemec GB; Tzellos T
Rev Endocr Metab Disord; 2016 Sep; 17(3):343-351. PubMed ID: 26831295
[TBL] [Abstract][Full Text] [Related]
7. Hidradenitis suppurativa in the pediatric population.
Liy-Wong C; Pope E; Lara-Corrales I
J Am Acad Dermatol; 2015 Nov; 73(5 Suppl 1):S36-41. PubMed ID: 26470613
[TBL] [Abstract][Full Text] [Related]
8. Metformin for the treatment of hidradenitis suppurativa: a little help along the way.
Verdolini R; Clayton N; Smith A; Alwash N; Mannello B
J Eur Acad Dermatol Venereol; 2013 Sep; 27(9):1101-8. PubMed ID: 22882365
[TBL] [Abstract][Full Text] [Related]
9. Lymecycline vs. clindamycin plus rifampicin in hidradenitis suppurativa treatment: clinical and ultrasonography evaluation.
Caposiena Caro RD; Molinelli E; Brisigotti V; Offidani A; Bianchi L
Clin Exp Dermatol; 2021 Jan; 46(1):96-102. PubMed ID: 32683727
[TBL] [Abstract][Full Text] [Related]
10. Analysis of Characteristics and Trends in Treatment Response of Hidradenitis Suppurativa Patients: A Southern US Cohort Study.
Peterson GC; Preston A; Frieder J; Wang X; Paek SY
Dermatology; 2020; 236(5):413-420. PubMed ID: 31935718
[TBL] [Abstract][Full Text] [Related]
11. Oral Metformin for Treating Dermatological Diseases: A Systematic Review.
Sung CT; Chao T; Lee A; Foulad DP; Choi F; Juhasz M; Dobry A; Mesinkovska NA
J Drugs Dermatol; 2020 Aug; 19(8):713-720. PubMed ID: 32845585
[TBL] [Abstract][Full Text] [Related]
12. Clindamycin versus clindamycin plus rifampicin in hidradenitis suppurativa treatment: Clinical and ultrasound observations.
Caposiena Caro RD; Cannizzaro MV; Botti E; Di Raimondo C; Di Matteo E; Gaziano R; Bianchi L
J Am Acad Dermatol; 2019 May; 80(5):1314-1321. PubMed ID: 30502416
[TBL] [Abstract][Full Text] [Related]
13. Failure of Anakinra in a Case of Severe Hidradenitis Suppurativa.
Russo V; Alikhan A
J Drugs Dermatol; 2016 Jun; 15(6):772-4. PubMed ID: 27272089
[TBL] [Abstract][Full Text] [Related]
14. Hidradenitis suppurativa: Clinical characteristics and determinants of treatment efficacy.
Vural S; Gündoğdu M; Akay BN; Boyvat A; Erdem C; Koçyiğit P; Bostancı S; Sanli H; Kundakci N
Dermatol Ther; 2019 Sep; 32(5):e13003. PubMed ID: 31237104
[TBL] [Abstract][Full Text] [Related]
15. Combination Therapies for Hidradenitis Suppurativa: A Retrospective Chart Review of 31 Patients.
McPhie ML; Bridgman AC; Kirchhof MG
J Cutan Med Surg; 2019; 23(3):270-276. PubMed ID: 30658534
[TBL] [Abstract][Full Text] [Related]
16. Hidradenitis suppurativa: A practical review of possible medical treatments based on over 350 hidradenitis patients.
Scheinfeld N
Dermatol Online J; 2013 Apr; 19(4):1. PubMed ID: 24021361
[TBL] [Abstract][Full Text] [Related]
17. Dapsone to Treat Moderate-to-Severe Hidradenitis Suppurativa: A Retrospective Case-Series.
Baroudi B; Bashyam AM; Feldman SR; Pichardo RO
J Drugs Dermatol; 2023 Nov; 22(11):e12-e16. PubMed ID: 37943259
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of ertapenem in severe hidradenitis suppurativa: a pilot study in a cohort of 30 consecutive patients.
Join-Lambert O; Coignard-Biehler H; Jais JP; Delage M; Guet-Revillet H; Poirée S; Duchatelet S; Jullien V; Hovnanian A; Lortholary O; Nassif X; Nassif A
J Antimicrob Chemother; 2016 Feb; 71(2):513-20. PubMed ID: 26565016
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of topical resorcinol 15% versus topical clindamycin 1% in the management of mild-to-moderate hidradenitis suppurativa: A retrospective study.
Molinelli E; Brisigotti V; Simonetti O; Sapigni C; D'Agostino GM; Rizzetto G; Giacchetti A; Offidani A
Dermatol Ther; 2022 Jun; 35(6):e15439. PubMed ID: 35278025
[TBL] [Abstract][Full Text] [Related]
20. An open-label study of anakinra for the treatment of moderate to severe hidradenitis suppurativa.
Leslie KS; Tripathi SV; Nguyen TV; Pauli M; Rosenblum MD
J Am Acad Dermatol; 2014 Feb; 70(2):243-51. PubMed ID: 24314876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
